NCT03458104

Brief Summary

  1. 1.The purpose of this study is to develop a validated computational model for assessing normative change in these patterns in patients with vocal cord atrophy before and after voice therapy.
  2. 2.This is a prospective study comparing two cohorts - patients with vocal cord atrophy(VCA) (G1) and healthy controls (G2). Subjects with VCA will receive a cone beam computed tomography (CBCT) scan with the standard laryngeal protocol before and after voice therapy. Healthy controls will also receive one cone beam computed tomography (CBCT) scan. Subjects with VCA (G1) will undergo post-therapy scans approximately 4 weeks after completion of voice therapy treatment. Enrolled subjects will also undergo a video stroboscopy and acoustic/aerodynamic testing. Subjects in G1 typically have these procedures performed before and after voice therapy as standard of care. Participants in G2 (healthy controls) will have the video stroboscopy and acoustic/aerodynamic testing just once since they would not otherwise be scheduled to undergo voice therapy. Potential subjects will be between 65 and 80 years of age will be considered for the study if they qualify based on inclusion criteria. Potential subjects will undergo are pre-screening process involving an initial telephone screening.
  3. 3.Raw data (measured and calculated) derived from this pilot study will be reported, and no statistical analysis will be performed. Data from specific aim 1 (G2) and specific aim 2 (G1) will be compared using graphical representations such as bar and dot plots. There is a potential for the loss of confidentiality; however, every reasonable effort will be made to limit breaches of privacy and confidentiality. Subjects may directly benefit from this study. In addition, data and conclusions derived from this study may help future patients regarding the effects of vocal therapy on vocal cord atrophy (VCA).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 8, 2018

Completed
20 days until next milestone

Study Start

First participant enrolled

March 28, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

April 7, 2020

Status Verified

April 1, 2020

Enrollment Period

2.4 years

First QC Date

February 9, 2018

Last Update Submit

April 3, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in acoustic/aerodynamic quantities as measured by the Phonatory Aerodynamic System

    Composite score of vital capacity, mean airflow rate, laryngeal airway resistance, maximum phonation duration, sound pressure level, frequency, aerodynamci dfficiency

    Baseline, 12 weeks

Secondary Outcomes (1)

  • Quantify changes in aerodynamic and aeroacoustics patterns in patients with vocal cord atrophy (VCA) before and after voice therapy.

    Baseline, 12 weeks

Study Arms (2)

Vocal Cord Atrophy

EXPERIMENTAL

Quantify changes in aerodynamic and aeroacoustics patterns in patients with vocal cord atrophy (VCA) before and after voice therapy. To evaluate changes, subjects will have Laryngovideostroboscopy, Acoustic/Auerodynamic testing, and Cone Beam CT scans of the larynx before and after voice therapy.

Other: Cone Beam Computed TomographyDiagnostic Test: Acoustic/Auerodynamic testingDiagnostic Test: Laryngovideostroboscopy

Healthy Volunteer

ACTIVE COMPARATOR

Develop a validated computational model for assessing normative laryngeal aerodynamic and aeroacoustic patterns in healthy elderly individuals. To assess normal laryngeal aerodynamic and aeroacoustic patterns in this cohort, subjects will subjects will have Laryngovideostroboscopy, Acoustic/Auerodynamic testing, and Cone Beam CT scans of the larynx.

Other: Cone Beam Computed TomographyDiagnostic Test: Acoustic/Auerodynamic testingDiagnostic Test: Laryngovideostroboscopy

Interventions

Cone Beam CT of the larynx

Healthy VolunteerVocal Cord Atrophy

Records and displays real-time sound pressure level intensity, intraoral pressure, airflow rate, and fundamental frequency

Healthy VolunteerVocal Cord Atrophy

Visualization of vocal cords in slow motion. It uses a stroboscopic lamp, which generates regular flashes of light. A flexible tube is inserted in the back of the mouth or through the nose and into the throat. Video pictures are then recorded while patients are making sound.

Healthy VolunteerVocal Cord Atrophy

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Between 65 and 80 years of age
  • Voice Handicap Index (VHI) questionnaire score of less than 10.
  • Little or no dysphonia as assessed by a speech language pathologist from the Duke Voice Care Center
  • No contraindications to have a CBCT scan (as assessed per standard clinical practice)

You may not qualify if:

  • Inability to speak, read, write, and understand English
  • Inability to provide written consent
  • Self-reported or known allergy to Afrin or Tetracaine HCL (or related class of drugs) and unable or willing to complete the laryngovideostroboscopy procedure with it.
  • Vocal Cord Atrophy Cohort:
  • Between 65 and 80 years of age
  • Clinical diagnosis of vocal cord atrophy (VCA)
  • Treated for the above condition by a provider at the Duke Head and Neck Surgery \& Communication Sciences Clinic
  • Elected to undergo voice therapy as standard of care for treatment of VCA
  • Other conditions that affect the voice and would interfere with study measures, as determined by PI
  • Inability to speak, read, write, and understand English
  • Inability to provide written consent
  • Self-reported or known allergy to Afrin or Tetracaine HCL (or related class of drugs) and unable or willing to complete the laryngovideostroboscopy procedure with it.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Study Officials

  • Dennis Frank-Ito, PhD

    Duke University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2018

First Posted

March 8, 2018

Study Start

March 28, 2018

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

April 7, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations